Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Trial to Evaluate the Efficacy of Supportive Therapy With Ginseng for Patients on Treatment With Regorafenib
Conditions
Interventions
Regorafenib
Ginseng
Locations
5
United States
Indiana Univeristy Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
IU Health Central Indiana Cancer Centers
Indianapolis, Indiana, United States
Altantic Health System
Morristown, New Jersey, United States
Comprehensive Cancer Center at Wake Forest Baptist
Winston-Salem, North Carolina, United States
Gettysburg Cancer Center
Gettysburg, Pennsylvania, United States
Start Date
April 1, 2016
Primary Completion Date
June 22, 2018
Completion Date
June 22, 2018
Last Updated
June 26, 2024
NCT07446322
NCT07541924
NCT07536113
NCT04693377
NCT07416552
NCT07529301
Lead Sponsor
Wake Forest University Health Sciences
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions